ACT RIZATRIPTAN ODT
ACTAVIS PHARMA COMPANY
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ACT RIZATRIPTAN ODT discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ACT RIZATRIPTAN ODT 5MG has been permanently discontinued (last updated October 22, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ACT RIZATRIPTAN ODT not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
MAXALT
MERCK CANADA INC
MAXALT RPD
ORGANON CANADA INC.
NAT-RIZATRIPTAN
NATCO PHARMA (CANADA) INC
RIZATRIPTAN
JUBILANT GENERICS LIMITED
CCP-RIZATRIPTAN ODT
CELLCHEM PHARMACEUTICALS INC.
MYLAN-RIZATRIPTAN
MYLAN PHARMACEUTICALS ULC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02374730
Strength
5MG
Dosage Form
TABLET (ORALLY DISINTEGRATING)
Route
ORAL
Compare with another product →
Shortage History
Other Products from ACTAVIS PHARMA COMPANY
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
4MG · DIN 02376520
DIN 02388650
5MG · DIN 02354462
100MG · DIN 02256142
38MG · DIN 02433117
DIN 02357402
DIN 02357410
DIN 02357399
20MG · DIN 02271478
5MG · DIN 02271443
10MG · DIN 02271451
25MG · DIN 02354829